Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha et al
- PMID: 33509796
- DOI: 10.1136/annrheumdis-2021-219866
Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha et al
Keywords: COVID-19; autoimmune diseases; epidemiology; health services research; vaccination.
Conflict of interest statement
Competing interests: CD received consulting/speaker’s fees from Abbvie, Eli Lilly, Janssen, Novartis, Pfizer, Roche and Sanofi, as well as grant support from Celgene, all unrelated to this manuscript. JWJB received honoraria from Lilly, Roche, Abbvie, Galapagos, SUN all unrelated to this manuscript. FB received consulting/speaker’s fees from Abbvie, Lilly, Horizon Therapeutics, Pfizer and Roche/Chugai, all unrelated to this manuscript.
Comment on
-
Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.Ann Rheum Dis. 2021 Oct;80(10):e170. doi: 10.1136/annrheumdis-2021-219847. Epub 2021 Jan 28. Ann Rheum Dis. 2021. PMID: 33509797 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical